Your browser doesn't support javascript.
loading
CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies.
Faeq, Mohammed Hikmat; Al-Haideri, Maysoon; Mohammad, Talar Ahmad Merza; Gharebakhshi, Farshad; Marofi, Faroogh; Tahmasebi, Safa; Modaresahmadi, Shadan.
Afiliación
  • Faeq MH; Student of General Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Al-Haideri M; Department of Physiotherapy, Cihan University-Erbil, Kurdistan Region, Erbil, Iraq.
  • Mohammad TAM; Department of Pharmacology, College of Pharmacy, Hawler Medical University, Kurdistan Region, Erbil, Iraq.
  • Gharebakhshi F; Department of Radiology, School of Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Marofi F; Department of Hematology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Tahmasebi S; Student Research Committee, Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. safa.tahmasebi@sbmu.ac.ir.
  • Modaresahmadi S; Department of Immunology and Biotechnology, Texas Tech University Health Siences Center, Abilene, TX, USA.
Med Oncol ; 40(5): 155, 2023 Apr 21.
Article en En | MEDLINE | ID: mdl-37083979

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia / Neoplasias Límite: Humans Idioma: En Revista: Med Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia / Neoplasias Límite: Humans Idioma: En Revista: Med Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Estados Unidos